Gordagen Reports Top-line Results of US Human Research (Clinical) Study for Muscle Recovery Supplement Life Science Investing
Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11 Life Science Investing
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment of Multiple Sclerosis Biotech Investing
BioQ Pharma Expands U.S. License and Supply Agreement to Commercialize Third Ready-to-Use Infusion Product Life Science Investing
CORRECTING and REPLACING Sucampo Standardizes on Veeva Vault for a Single Source of Truth and Enterprise-wide Capability Biotech Investing
Gradalis, Inc. Announces Initiation of a Phase 2 Study using Gradalis’ Vigil® Immunotherapy in Combination with Anti-PD-1 Technology to Treat Patients with Advanced Non-Small Cell Lung Cancer Biotech Investing
Inovio Pharmaceuticals to Report First Quarter 2016 Financial Results May 9, 2016 Life Science Investing
U.S. FDA Approves Rockwell’s Triferic® Powder Packet for Treating Anemia in Hemodialysis Patients Biotech Investing
Minerva Neurosciences to Report First Quarter 2016 Financial Results and Business Updates on May 3, 2016 Biotech Investing
